摘要
肝癌血管性介入治疗临床主要有3种治疗方式,分别为肝动脉灌注治疗(TAI)、肝动脉栓塞(TAE)和肝动脉化疗栓塞(TACE)。3种治疗方式的区别在于肝动脉灌注治疗主要是通过导管向动脉内灌注化疗药物;肝动脉栓塞主要是通过导管将明胶海绵、碘化油等栓塞剂注入肿瘤供血动脉;肝动脉化疗栓塞则是经导管既灌注化疗药物,又使用栓塞剂,目前在临床广泛应用。在编码肝癌血管性介入治疗的操作时,首先要通读操作记录来区分本次介入治疗的方式,明确是单纯灌注化疗药物还是物理性栓塞,或者是两者同时进行,选择性肝动脉灌注治疗一般需要3个编码,分别为99.25注射或输注癌瘤化学治疗药物,50.93肝局部灌注和88.47其他腹内动脉造影术(肝动脉造影)。选择性肝动脉栓塞一般需要2个编码,分别为39.79为其他血管的其他血管内修补术(肝动脉栓塞术)和88.47其他腹内动脉造影术(肝动脉造影)。选择性肝动脉化疗栓塞一般需要4个编码,分别为99.25注射或输注癌瘤化学治疗药物,50.93肝局部灌注(灌注部位),39.79为其他血管的其他血管内修补术(肝动脉栓塞术)和88.47其他腹内动脉造影术(肝动脉造影)。编码时注意不要遗漏附加编码和另编码。
There are three main clinical methods of vascular interventional therapy for liver cancer,namely hepatic artery perfusion therapy(TAI)hepatic artery embolization(TAE)and hepatic artery chemoembolization(TACE).Hepatic artery embolization is mainly performed by injecting embolization agents such as gelfoam iodide oil into tumor supply arteries through catheters.Hepatic artery embolism chemotherapy is the catheter perfusion chemotherapy drugs,and using embolism agent,is currently in clinical widely used in the coding of vascular interventional treatment of liver cancer operation,the first thing to read through the operation records to distinguish the interventional treatment way,clear pure perfusion chemotherapy drugs or physical embolism,or both simultaneously,selective hepatic artery perfusion treatment generally requires three coding,cancerous tumors were 99.25 injection or infusion chemotherapy drugs,selective hepatic artery embolization generally requires two codes,39.79 for other vessels other endovascular repair(hepatic artery embolization)and 88.47 for other vessels other endovascular angiography(hepatic arteriography).Selective hepatic artery embolism chemotherapy generally takes four coding,cancerous tumors were 99.25 injection or infusion chemotherapy drugs,50.93 partial liver perfusion(perfusion),39.79 for other vessels other endovascular repair(hepatic artery embolization),and 88.47 other abdominal arteriography(hepatic artery angiography)coding don’t leave out additional coding and pay attention to the other coding.
作者
盛春蕊
侯春超
赵娴
邢瑶
Sheng Chunrui;Hou Chunchao;Zhao Xian;Xing Yao(Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China;不详)
出处
《中国病案》
2020年第3期34-36,共3页
Chinese Medical Record
基金
北京中医药大学2019年度基本科研业务(2019-JYB-JS-126)。
关键词
肝癌
血管性介入
操作编码
Cancer of the liver
Vascular intervention
Operation code